Neuberger Berman Group
ALXN

Neuberger Berman Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-769,228
Closed -$141M 1874
2021
Q2
$141M Sell
769,228
-34,812
-4% -$6.39M 0.12% 248
2021
Q1
$123M Sell
804,040
-139,119
-15% -$21.3M 0.12% 258
2020
Q4
$147M Sell
943,159
-204,277
-18% -$31.9M 0.15% 196
2020
Q3
$131M Buy
1,147,436
+17,301
+2% +$1.98M 0.16% 186
2020
Q2
$127M Sell
1,130,135
-155,409
-12% -$17.4M 0.16% 178
2020
Q1
$115M Sell
1,285,544
-116,087
-8% -$10.4M 0.18% 161
2019
Q4
$152M Sell
1,401,631
-154,455
-10% -$16.7M 0.18% 165
2019
Q3
$152M Buy
1,556,086
+387,322
+33% +$37.9M 0.19% 160
2019
Q2
$153M Buy
1,168,764
+165,547
+17% +$21.7M 0.18% 155
2019
Q1
$136M Buy
1,003,217
+131,073
+15% +$17.7M 0.17% 177
2018
Q4
$84.9M Buy
872,144
+286,256
+49% +$27.9M 0.12% 258
2018
Q3
$81.4M Buy
585,888
+61,309
+12% +$8.52M 0.09% 307
2018
Q2
$65.1M Buy
524,579
+145,400
+38% +$18.1M 0.07% 347
2018
Q1
$42.3M Buy
379,179
+57,591
+18% +$6.42M 0.05% 447
2017
Q4
$38.5M Buy
321,588
+50,417
+19% +$6.03M 0.04% 467
2017
Q3
$38M Sell
271,171
-1,192
-0.4% -$167K 0.05% 451
2017
Q2
$33.1M Buy
272,363
+266,174
+4,301% +$32.4M 0.04% 485
2017
Q1
$750K Buy
6,189
+1,423
+30% +$172K ﹤0.01% 1202
2016
Q4
$583K Buy
4,766
+1,980
+71% +$242K ﹤0.01% 1255
2016
Q3
$341K Sell
2,786
-1,851
-40% -$227K ﹤0.01% 1358
2016
Q2
$541K Buy
+4,637
New +$541K ﹤0.01% 1229
2014
Q3
Sell
-247,836
Closed -$38.7M 1717
2014
Q2
$38.7M Sell
247,836
-7,498
-3% -$1.17M 0.04% 493
2014
Q1
$38.8M Sell
255,334
-2,136
-0.8% -$325K 0.04% 477
2013
Q4
$34.2M Buy
257,470
+42,092
+20% +$5.59M 0.04% 495
2013
Q3
$25M Sell
215,378
-30,424
-12% -$3.53M 0.03% 568
2013
Q2
$22.7M Buy
+245,802
New +$22.7M 0.03% 570